Focaccetti et al., 2019 - Google Patents
Polyphenols as immunomodulatory compounds in the tumor microenvironment: friends or foes?Focaccetti et al., 2019
View HTML- Document ID
- 10459355569929006499
- Author
- Focaccetti C
- Izzi V
- Benvenuto M
- Fazi S
- Ciuffa S
- Giganti M
- Potenza V
- Manzari V
- Modesti A
- Bei R
- Publication year
- Publication venue
- International journal of molecular sciences
External Links
Snippet
Polyphenols are natural antioxidant compounds ubiquitously found in plants and, thus, ever present in human nutrition (tea, wine, chocolate, fruits and vegetables are typical examples of polyphenol-rich foods). Widespread evidence indicate that polyphenols exert strong …
- 150000008442 polyphenolic compounds 0 title abstract description 108
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/02—Algae
- A61K36/05—Chlorophycota or chlorophyta (green algae), e.g. Chlorella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Focaccetti et al. | Polyphenols as immunomodulatory compounds in the tumor microenvironment: friends or foes? | |
| Alesci et al. | Resveratrol and immune cells: a link to improve human health | |
| Mitra et al. | Exploring the immune-boosting functions of vitamins and minerals as nutritional food bioactive compounds: A comprehensive review | |
| Lee et al. | The role of vitamin E in immunity | |
| Bleve et al. | Lipid metabolism and cancer immunotherapy: immunosuppressive myeloid cells at the crossroad | |
| Qi et al. | Protective effect of bergenin against cyclophosphamide-induced immunosuppression by immunomodulatory effect and antioxidation in Balb/c mice | |
| Huang et al. | Clinacanthus nutans (Burm. f.) Lindau ethanol extract inhibits hepatoma in mice through upregulation of the immune response | |
| Huang et al. | Licochalcone A inhibits cellular motility by suppressing E-cadherin and MAPK signaling in breast cancer | |
| Mao et al. | Glycyrrhizic acid promotes M1 macrophage polarization in murine bone marrow‐derived macrophages associated with the activation of JNK and NF‐κB | |
| Wang et al. | Targeting myeloid-derived suppressor cells in cancer immunotherapy | |
| Melisi et al. | Toll-like receptor 9 agonists for cancer therapy | |
| Chang et al. | Improved chemotherapeutic activity by Morus alba fruits through immune response of toll-like receptor 4 | |
| Ravindran Menon et al. | Egcg inhibits tumor growth in melanoma by targeting jak-stat signaling and its downstream Pd-L1/Pd-L2-Pd1 axis in tumors and enhancing cytotoxic T-cell responses | |
| Tang et al. | Anti-tumor effects of the polysaccharide isolated from tarphochlamys affinis in H22 tumor-bearing mice | |
| Han et al. | Immunostimulatory potential of extracellular vesicles isolated from an edible plant, petasites japonicus, via the induction of murine dendritic cell maturation | |
| Jie et al. | CpG ODN1826 as a promising mucin1-maltose-binding protein vaccine adjuvant induced DC maturation and enhanced antitumor immunity | |
| Khoury et al. | “The two sides of the same coin”—Medical cannabis, cannabinoids and immunity: Pros and cons explained | |
| Grabowska et al. | Liposomal nanovaccine containing α-galactosylceramide and ganglioside GM3 stimulates robust CD8+ T cell responses via CD169+ macrophages and cDC1 | |
| Benvenuto et al. | The potential protective effects of polyphenols in asbestos-mediated inflammation and carcinogenesis of mesothelium | |
| Kim et al. | Annona muricata L.-derived Polysaccharides as a potential adjuvant to a dendritic cell-based vaccine in a Thymoma-bearing model | |
| Murgaski et al. | Unleashing tumour-dendritic cells to fight cancer by tackling their three A’s: abundance, activation and antigen-delivery | |
| Wang et al. | Intranasal administration of Codium fragile polysaccharide elicits anti-cancer immunity against Lewis lung carcinoma | |
| Shen et al. | Liposomal β-sitosterol suppresses metastasis of CT26/luc colon carcinoma via inhibition of MMP-9 and evoke of immune system | |
| Huang et al. | Natural products for the immunotherapy of glioma | |
| Giri et al. | Immunomodulatory role of microbial surfactants, with special emphasis on fish |